NFA
ARCT icon

Nationwide Fund Advisors’s Arcturus Therapeutics ARCT Stock Holding History

Nationwide Fund Advisors’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-714
Closed -$77K – 3249
2014
Q3 		$77K Buy
+714
New +$93K ﹤0.01% 3047

Other funds holding ARCT

KCM
Knoll Capital Management Miami, Florida $214M AUM 62.74% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
LCM
Leisure Capital Management Costa Mesa, California $320M AUM 39.11% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Nationwide Fund Advisors's ARCT Position: Q4 2014 in Review

Nationwide Fund Advisors sold out of Arcturus Therapeutics (ARCT) in Q4 2014, closing a stake of 714 shares — an estimated $77K sold.

Nationwide Fund Advisors first reported a position in ARCT in Q3 2014 and held it in 1 quarter. The position peaked at $77K in Q3 2014. 28 funds tracked by Wall St. Rank hold ARCT as of Q4 2014.

  • Nationwide Fund Advisors reported no remaining Arcturus Therapeutics position as of Q4 2014 after selling out during the quarter.
  • Nationwide Fund Advisors sold 714 Arcturus Therapeutics shares in Q4 2014, an estimated $77K.
  • Nationwide Fund Advisors first reported a position in Arcturus Therapeutics in Q3 2014 and held it in 1 quarter.
  • Nationwide Fund Advisors's Arcturus Therapeutics position peaked at $77K in Q3 2014.
  • 28 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q4 2014.

Based on Nationwide Fund Advisors's 13F filing for Q4 2014, filed 10 Feb 2015.